KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Restructuring Costs (2010 - 2026)

Johnson & Johnson recorded quarterly Restructuring Costs of $32.0 million in Q1 2026, down 61.9% quarter-over-quarter from $84.0 million in Q4 2025, and up 88.24% year-over-year from $17.0 million in Q1 2025.

Johnson & Johnson's Restructuring Costs history runs 14 years deep, the most recent figure standing at $32.0 million for Q1 2026.

  • In Q1 2026, Restructuring Costs rose 88.24% year-over-year to $32.0 million; the TTM figure through Mar 2026 stood at $243.0 million (up 179.31% YoY), while the FY2025 annual figure was $228.0 million, down 2.56% from the prior year.
  • Restructuring Costs came in at $32.0 million for Q1 2026 at Johnson & Johnson, down from $84.0 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $164.0 million in Q1 2024 to a low of -$13.0 million in Q2 2024.
  • A 5-year average of $77.0 million and a median of $65.0 million in 2022 frame the typical range for Restructuring Costs.
  • Across the five-year window, Restructuring Costs slumped 108.97% in 2024 and surged 592.31% in 2025, its largest moves.
  • Johnson & Johnson's Restructuring Costs stood at $65.0 million in 2022, then decreased by 13.85% to $56.0 million in 2023, then fell by 25.0% to $42.0 million in 2024, then jumped by 100.0% to $84.0 million in 2025, then tumbled by 61.9% to $32.0 million in 2026.
  • According to Business Quant data, Restructuring Costs over the past three periods registered $32.0 million, $84.0 million, and $63.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 32.00 Mn
Dec 28, 2025 84.00 Mn
Sep 28, 2025 63.00 Mn
Jun 29, 2025 64.00 Mn
Mar 30, 2025 17.00 Mn
Dec 29, 2024 42.00 Mn
Sep 29, 2024 41.00 Mn
Jun 30, 2024 -13.00 Mn
Mar 31, 2024 164.00 Mn
Dec 31, 2023 56.00 Mn
Oct 1, 2023 158.00 Mn
Jul 2, 2023 145.00 Mn
Apr 2, 2023 130.00 Mn
Jan 1, 2023 106.00 Mn
Oct 2, 2022 65.00 Mn
Jul 3, 2022 85.00 Mn
Apr 3, 2022 70.00 Mn
Oct 3, 2021 60.00 Mn
Jul 4, 2021 56.00 Mn
Apr 4, 2021 53.00 Mn
Jan 3, 2021 60.00 Mn
Sep 27, 2020 68.00 Mn
Jun 28, 2020 61.00 Mn
Mar 29, 2020 58.00 Mn
Dec 29, 2019 251.00 Mn
Sep 29, 2019 69.00 Mn
Jun 30, 2019 57.00 Mn
Mar 31, 2019 36.00 Mn
Dec 30, 2018 227.00 Mn
Sep 30, 2018 190.00 Mn
Jul 1, 2018 176.00 Mn
Apr 1, 2018 107.00 Mn
Dec 31, 2017 284.00 Mn
Oct 1, 2017 187.00 Mn
Jul 2, 2017 128.00 Mn
Apr 2, 2017 161.00 Mn
Jan 1, 2017 298.00 Mn
Oct 2, 2016 109.00 Mn
Jul 3, 2016 141.00 Mn
Apr 3, 2016 137.00 Mn
Jan 3, 2016 590.00 Mn
Dec 30, 2012 -589.00 Mn
Jul 3, 2011 589.00 Mn
Jan 3, 2010 1.20 Bn